Wolverine Trading, LLC Takeda Pharmaceutical CO LTD Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $136,651 - $170,166	-10,376 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $145,070 - $153,614	-8,900 Reduced 46.17%	10,376 $169,000
Q2 2021 Aug 06, 2021	SELL	$16.55 - $18.64 $9,052 - $10,196	-547 Reduced 2.76%	19,276 $324,000
Q1 2021 May 14, 2021	SELL	$16.71 - $19.9 $219,318 - $261,187	-13,125 Reduced 39.84%	19,823 $364,000
Q4 2020 Feb 12, 2021	BUY	$15.39 - $18.97 $507,069 - $625,023	32,948 New	32,948 $599,000

320

70.4M

939K

233K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $43.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.